About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
Key points
- Confirm true hematuria with urine microscopy — dipstick blood can reflect RBCs, free haemoglobin, or myoglobin
- First split: glomerular hematuria (proteinuria, dysmorphic RBCs, red cell casts, hypertension, oedema, elevated creatinine) vs non-glomerular/urological hematuria
- Gross painless hematuria in an older smoker is bladder or upper tract malignancy until proven otherwise — refer for cystoscopy and upper tract imaging
- Hematuria with flank colic suggests stone; hematuria with dysuria/frequency suggests cystitis; hematuria after trauma requires trauma imaging pathways
- Do not dismiss hematuria because the patient is anticoagulated — anticoagulation may unmask pathology and does not eliminate the need for assessment
Approach to the Presentation
Hematuria can be visible (gross/macroscopic) or detected only on microscopy. The MCC objective emphasizes interpreting urinalysis and distinguishing glomerular from non-glomerular causes. A structured approach begins with: (1) confirm true RBC hematuria with microscopy; (2) assess urgency — clot retention, trauma, sepsis, AKI, suspected stone obstruction, or rapidly progressive glomerulonephritis; (3) localize the source using urine sediment, proteinuria, renal function, symptoms, age, smoking history, occupational exposures, medications, and malignancy risk; and (4) decide whether the patient needs nephrology, urology, or emergency referral. The dangerous misses are urothelial malignancy, renal tumour, obstructing infected stone, glomerulonephritis with rapidly declining kidney function, and traumatic urinary tract injury.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Bladder cancer / upper tract urothelial carcinoma | must-not-miss | Painless gross hematuria, older age, smoking, occupational aromatic amine exposure, irritative LUTS, recurrent “UTIs” with negative cultures | Cystoscopy + CT urogram or renal/bladder imaging depending on renal function and risk |
| Renal cell carcinoma | must-not-miss | Hematuria with flank mass/pain, weight loss, fever, anaemia or polycythaemia, hypercalcaemia; may be incidental | Contrast CT abdomen/renal mass protocol or MRI if contrast contraindicated |
| Glomerulonephritis / nephritic syndrome | must-not-miss | Cola-coloured urine, hypertension, oedema, proteinuria, dysmorphic RBCs or red cell casts, rising creatinine; systemic features of lupus/vasculitis | Urine microscopy + ACR/PCR + creatinine/eGFR; serologies; nephrology assessment ± renal biopsy |
| Traumatic urinary tract injury | must-not-miss | Gross hematuria after blunt/penetrating trauma, pelvic fracture, flank ecchymosis, inability to void, blood at meatus | CT trauma imaging with delayed phase; retrograde urethrogram before catheter if urethral injury suspected |
| Urolithiasis | common | Severe colicky flank pain radiating to groin, nausea/vomiting, restlessness, microscopic or gross hematuria | Non-contrast low-dose CT KUB; ultrasound in pregnancy/children or when avoiding radiation |
| Urinary tract infection / cystitis | common | Dysuria, frequency, urgency, suprapubic discomfort, pyuria, nitrites/leukocyte esterase; hematuria can occur | Urinalysis ± urine culture depending on complexity, pregnancy, recurrence, or male sex |
| Benign prostatic hyperplasia / prostatic bleeding | common | Older male with LUTS, enlarged smooth prostate, terminal hematuria; may coexist with malignancy | DRE, urinalysis, creatinine, PSA discussion; urology evaluation if hematuria persists or gross hematuria |
| Exercise-induced hematuria | less common | Transient microscopic hematuria after strenuous exercise, resolves within 48-72 hours, no proteinuria or casts | Repeat urinalysis after rest |
| Drug-related / anticoagulant-associated hematuria | less common | Warfarin/DOACs, cyclophosphamide, radiation cystitis; bleeding may unmask underlying pathology | Medication review, INR if on warfarin; still investigate persistent or gross hematuria |
| Pseudohematuria / pigmenturia | less common | Red/brown urine with few or no RBCs on microscopy: beetroot, rifampin, phenazopyridine, haemoglobinuria, myoglobinuria | Urine microscopy; CK if rhabdomyolysis suspected; haemolysis labs if haemoglobinuria |
Red Flags & Key History
Symptoms
Painless gross hematuria, especially age >40 or smoker — urothelial malignancy until proven otherwise
Hematuria with oliguria, oedema, hypertension, or dark cola-coloured urine — glomerulonephritis
Hematuria with fever, flank pain, rigors, or sepsis — pyelonephritis or infected obstructing stone
Hematuria after trauma, pelvic fracture, inability to void, or blood at the meatus — urinary tract injury
Hematuria with clots and urinary retention — clot retention requiring urgent urological management
Hematuria with colicky flank-to-groin pain — renal/ureteric stone
Hematuria with dysuria and frequency — cystitis or urethritis, but culture-negative recurrence warrants broader assessment
Signs
Hypertension, periorbital oedema, peripheral oedema — nephritic syndrome or renal disease
Flank mass or cachexia — renal malignancy
Costovertebral angle tenderness with fever — pyelonephritis or infected obstruction
Blood at urethral meatus or high-riding prostate after trauma — urethral injury
Suprapubic tenderness with urinary retention — clot retention or bladder outlet obstruction
Approach to Investigation
First-line
Urinalysis with microscopyConfirm RBCs. Look for protein, leukocytes, nitrites, casts, dysmorphic RBCs, specific gravity. Dipstick blood with absent RBCs suggests haemoglobinuria or myoglobinuria
Urine culture when infection possibleEspecially if dysuria, pyuria, pregnancy, male sex, recurrent symptoms, fever, or complicated UTI risk factors
Serum creatinine/eGFR, electrolytes, CBCAssess renal impairment, anaemia, infection, and safety of contrast imaging
Urine ACR or PCRProteinuria supports glomerular disease and affects nephrology referral urgency
Second-line
Renal/bladder ultrasound or CT urogramUpper tract imaging for persistent microscopic hematuria or any gross hematuria, tailored to age, renal function, pregnancy, stone suspicion, and malignancy risk
CystoscopyRequired for gross hematuria or high-risk microscopic hematuria because bladder lesions may be missed by imaging alone
Glomerulonephritis serologiesIf proteinuria, casts, renal impairment, or systemic features: complements, ANA, anti-dsDNA, ANCA, anti-GBM, hepatitis B/C, HIV, serum immunoglobulins as appropriate
Specialist
Renal biopsyFor suspected glomerulonephritis, nephrotic/nephritic syndrome, unexplained proteinuria with renal impairment, or rapidly progressive kidney disease
Trauma CT with delayed excretory phase / retrograde urethrogramFor suspected renal, bladder, ureteric, or urethral injury after trauma
Management Principles
MCC Hematuria Objective + CUA hematuria/urology guidance + Canadian primary care pathways1
Confirm and triage
- Confirm true hematuria with microscopy rather than relying on dipstick alone
- Stabilize and refer urgently if clot retention, sepsis, AKI, traumatic urinary tract injury, suspected infected obstruction, or rapidly progressive glomerulonephritis
- Assess anticoagulants/antiplatelets, but do not attribute persistent or gross hematuria solely to medication
2
Glomerular hematuria pathway
- If proteinuria, casts, dysmorphic RBCs, hypertension, oedema, or elevated creatinine: quantify proteinuria, check renal function/electrolytes, and refer to nephrology
- If rapidly progressive renal impairment, pulmonary haemorrhage, severe hypertension, or nephritic syndrome: same-day ED/nephrology assessment
3
Urological hematuria pathway
- Gross hematuria generally warrants urology referral for cystoscopy and upper tract imaging
- Microscopic hematuria: risk-stratify by age, smoking, occupational exposure, irritative symptoms, persistence, and imaging suitability
- Treat proven UTI, then repeat urinalysis to ensure hematuria resolves
4
Patient counselling and follow-up
- Explain that visible hematuria requires evaluation even if painless or transient
- Arrange repeat urinalysis after transient triggers such as exercise, menses contamination, or infection
- Provide return precautions for retention, fever, worsening flank pain, reduced urine output, or systemic symptoms
Complications & Pitfalls
- Dipstick trap: A positive blood dipstick is not the same as microscopic RBC hematuria; confirm with microscopy.
- Anticoagulation trap: Do not dismiss hematuria as “just warfarin” or “just a DOAC”; malignancy and stones can still be present.
- Infection anchoring: Recurrent “UTIs” with hematuria in an older adult, especially with negative cultures, should trigger malignancy assessment.
- Missed glomerular disease: Proteinuria, red cell casts, hypertension, or rising creatinine shift the pathway to nephrology rather than routine urology alone.
- Trauma catheter error: Blood at the meatus after pelvic trauma requires retrograde urethrogram before urethral catheterization.
MCCQE1 Exam Tips
- 1For hematuria, the MCC objective explicitly tests urinalysis interpretation and glomerular vs non-glomerular localization
- 2Painless gross hematuria in an older smoker = bladder cancer until proven otherwise; the next best step is urological evaluation with cystoscopy and upper tract imaging
- 3Red cell casts or dysmorphic RBCs = glomerular bleeding; add creatinine/eGFR, ACR/PCR, serology, and nephrology referral
- 4Hematuria + flank colic = stone; hematuria + fever + obstruction = infected obstructing stone, which is a urological emergency
- 5Dipstick positive blood with no RBCs on microscopy suggests myoglobinuria or haemoglobinuria — check CK if rhabdomyolysis is possible
- 6Treat a documented UTI, but repeat urinalysis after treatment; persistent hematuria needs further work-up
- 7Do not order urine cytology as the sole “rule-out cancer” test; cystoscopy is the key test for bladder pathology
Put your reading into practice
Checking available topic practice…
Choose MCCQE Part I questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.
Choose MCCQE Part I practiceAfter your session, return to this section to revisit the reading and choose your next review.
regional clinical guidance
Hematuria (Microscopic & Gross): guidance by region
Recommendations, thresholds and pathways can differ. Open the page written for the jurisdiction you need.
Verified Sources & References
related resources
Save your place and choose what comes next
Renal & Urological · Article 14 of 36